South African coronavirus variant found in the Netherlands The South African variant of the coronavirus (501Y.V2) has been identified in the Netherlands for the first time.
Update on the spread of the UK coronavirus variant (VOC 202012/01) in the Netherlands The number of people that have been found to have the new SARS-CoV-2 coronavirus variant designated VOC 202012/01 (the UK variant) has risen from 11 to nearly 50 individuals.
First COVID-19 vaccination in the Netherlands given at GGD vaccination site in Veghel Care workers in nursing homes and small-scale residential facilities received the first COVID-19 vaccinations in the Netherlands this morning at the GGD vaccination location ‘Hart voor Brabant’ in
Decisive decrease not yet visible Decisive effects from the lockdown of 15 December have yet to be seen. Although there was a decrease in the number of people who were tested and the number of people who tested positive for COVID-19.
Care workers in nursing homes and small-scale residential facilities invited for COVID-19 vaccination starting today As of today, the ca. 269,000 care workers of nursing homes and small-scale residential facilities in the Netherlands are invited to make an appointment for a COVID-19 vaccination.
Changed indicative magnetic field zones around overhead high-voltage lines RIVM has updated the 2005 grid map (Netkaart) showing the overhead high-voltage lines in the Netherlands.
INHERIT Model: a tool to jointly improve health, environmental sustainability and Health Equity RIVM is involved in the Horizon2020 project INHERIT. The first article of the INHERIT project has been published, lead-authored by RIVM.
RIVM on shortlist Best Government Organisation of the Year 2018 The National Institute for Public Health and the Environment (RIVM) has made the shortlist for the 2018 election for best government organisation of the year.
RIVM supports WHO in national capacity building for measuring foodborne disease burden RIVM’s Collaborating Centre for Risk Assessment of Pathogens in Food and Water was invited to WHO’s side event during the 41st Codex Alimentarius Commission on July 4th 2018.
Rapid developments in modern biotechnology are a challenge for risk assessment Due to developments in modern biotechnology, such as genome editing, synthetic biology and regulation of gene expression, many new applications are expected in the next ten years.